Review
Prognostic factors for randomization and stratification and endpoints for the evaluation of trials
Affiliations
- PMID: 3293065
Item in Clipboard
Review
Prognostic factors for randomization and stratification and endpoints for the evaluation of trials
Prog Clin Biol Res.
1988.
No abstract available
Similar articles
-
Design and analysis of prostate cancer trials.Acta Urol Belg. 1994 Apr;62(1):23-9. Acta Urol Belg. 1994. PMID: 8197926
-
Designing for cancer clinical trials: selection of prognostic factors.Cancer Treat Rep. 1980 Feb-Mar;64(2-3):499-502. Cancer Treat Rep. 1980. PMID: 7407790
-
Objective response criteria in phase II and phase III studies.Prog Clin Biol Res. 1988;269:243-60. Prog Clin Biol Res. 1988. PMID: 3293063 Review. No abstract available.
-
[Use of prognostic knowledge in the planning and analysis of randomized therapeutic trials].Bull Cancer. 1987;74(2):177-84. Bull Cancer. 1987. PMID: 3607300 French.
-
Criteria for evaluating patient responses to treatment modalities for prostatic cancer.Urol Clin North Am. 1984 May;11(2):337-42. Urol Clin North Am. 1984. PMID: 6375069 Review.
Cited by
-
The significance of erythrocyte sedimentation rate as a prognostic factor for patients with prostate cancer: Gunma Urological Oncology Study Group investigation.Jpn J Cancer Res. 1990 Oct;81(10):971-4. doi: 10.1111/j.1349-7006.1990.tb03333.x. Jpn J Cancer Res. 1990. PMID: 2121683 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Medical